X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (743) 743
continuous subcutaneous insulin infusion (630) 630
index medicus (522) 522
female (483) 483
endocrinology & metabolism (455) 455
male (450) 450
type 1 diabetes (404) 404
continuous glucose monitoring (386) 386
diabetes mellitus, type 1 - drug therapy (355) 355
insulin - administration & dosage (354) 354
diabetes (345) 345
adult (338) 338
insulin (336) 336
insulin infusion systems (303) 303
hypoglycemia (267) 267
diabetes mellitus, type 1 - blood (258) 258
hypoglycemic agents - administration & dosage (257) 257
middle aged (252) 252
glucose (246) 246
glycemic control (217) 217
blood glucose - analysis (215) 215
blood glucose - metabolism (175) 175
insulin - therapeutic use (173) 173
diabetes mellitus (171) 171
insulin pump (171) 171
children (164) 164
hypoglycemic agents - therapeutic use (137) 137
adolescent (136) 136
child (133) 133
medicine & public health (131) 131
therapy (129) 129
blood sugar monitoring (128) 128
type 1 diabetes mellitus (122) 122
aged (121) 121
adolescents (120) 120
treatment outcome (120) 120
pediatrics (116) 116
internal medicine (115) 115
multiple daily injections (115) 115
infusion (111) 111
mellitus (105) 105
pump therapy (102) 102
diabetes therapy (99) 99
hyperglycemia (97) 97
care and treatment (95) 95
glycated hemoglobin a - analysis (95) 95
type 2 diabetes (92) 92
injections, subcutaneous (90) 90
quality of life (89) 89
original (88) 88
artificial pancreas (86) 86
original articles (85) 85
glycated hemoglobin a - metabolism (82) 82
blood sugar (79) 79
blood-glucose (79) 79
dextrose (79) 79
time factors (79) 79
analysis (78) 78
young adult (75) 75
severe hypoglycemia (72) 72
blood glucose - drug effects (71) 71
insulin - adverse effects (71) 71
insulin pump therapy (71) 71
insulin pumps (71) 71
metabolic diseases (69) 69
pregnancy (69) 69
diabetes mellitus, type 2 - drug therapy (68) 68
infusions, subcutaneous (68) 68
retrospective studies (68) 68
hypoglycemic agents - adverse effects (67) 67
blood glucose self-monitoring - instrumentation (65) 65
usage (65) 65
adults (64) 64
blood glucose self-monitoring (64) 64
hypoglycaemia (64) 64
algorithms (63) 63
blood glucose self-monitoring - methods (63) 63
complications (63) 63
health aspects (62) 62
quality-of-life (62) 62
management (60) 60
drug administration schedule (59) 59
hypoglycemia - prevention & control (58) 58
blood glucose (56) 56
glycosylated hemoglobin (55) 55
insulin infusion systems - adverse effects (55) 55
child, preschool (54) 54
review (53) 53
animals (52) 52
sensors (52) 52
accuracy (51) 51
csii (51) 51
diabetes mellitus, type 2 - blood (51) 51
patient monitoring equipment (51) 51
pharmacology & pharmacy (51) 51
research (50) 50
diabetes mellitus - drug therapy (49) 49
type-1 (49) 49
endocrinology (48) 48
follow-up studies (48) 48
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1236) 1236
German (37) 37
Spanish (23) 23
Japanese (12) 12
French (11) 11
Polish (7) 7
Czech (6) 6
Korean (6) 6
Italian (5) 5
Hungarian (2) 2
Icelandic (2) 2
Chinese (1) 1
Estonian (1) 1
Finnish (1) 1
Portuguese (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes/Metabolism Research and Reviews, ISSN 1520-7552, 01/2016, Volume 32, Issue 1, pp. 21 - 39
Summary The level of glycaemic control necessary to achieve optimal short‐term and long‐term outcomes in subjects with type 1 diabetes mellitus (T1DM)... 
continuous subcutaneous insulin infusion | diabetes mellitus | rapid‐acting insulin analogue | pharmacoeconomics | pregnancy | paediatric | Pregnancy | Rapid-acting insulin analogue | Pharmacoeconomics | Paediatric | Diabetes mellitus | Continuous subcutaneous insulin infusion | MULTIPLE DAILY INJECTIONS | GLYCEMIC CONTROL | ARTIFICIAL PANCREAS | SEVERE HYPOGLYCEMIA | AUGMENTED PUMP THERAPY | RANDOMIZED CONTROLLED-TRIAL | METABOLIC-CONTROL | CLOSED-LOOP CONTROL | rapid-acting insulin analogue | ENDOCRINOLOGY & METABOLISM | QUALITY-OF-LIFE | BLOOD-GLUCOSE CONTROL | Insulin, Short-Acting - adverse effects | Insulin, Short-Acting - economics | Hypoglycemic Agents - economics | Insulin, Short-Acting - administration & dosage | Humans | Insulins - economics | Hypoglycemia - prevention & control | Hypoglycemic Agents - administration & dosage | Computer Security | Insulin Infusion Systems - economics | Hypoglycemia - chemically induced | Precision Medicine | Hypoglycemic Agents - therapeutic use | Hyperglycemia - prevention & control | Blood Glucose - analysis | Insulins - administration & dosage | Europe | Insulin Infusion Systems - adverse effects | Evidence-Based Medicine | Insulin Infusion Systems - trends | Diabetes Mellitus, Type 1 - drug therapy | Infusions, Subcutaneous | Monitoring, Ambulatory | Health Care Costs | Diabetes Mellitus, Type 1 - economics | Diabetes Mellitus, Type 1 - blood | Quality of Life | Insulins - therapeutic use | Hypoglycemic Agents - adverse effects | Insulins - adverse effects | Insulin, Short-Acting - therapeutic use | Insulin | Diabetes | Hyperglycemia | Patient satisfaction | Quality of life | Life Sciences | Human health and pathology | Endocrinology and metabolism | Review
Journal Article
Journal Article
Diabetes & Metabolism, ISSN 1262-3636, 2011, Volume 37, Issue 5, pp. 426 - 431
Journal Article
Pediatric Diabetes, ISSN 1399-543X, 06/2017, Volume 18, Issue 4, pp. 255 - 261
Continuous subcutaneous insulin infusion (CSII) is a very common therapy for children with type 1 diabetes. Due to physiological differences they have other... 
continuous subcutaneous insulin infusion | bolus advisor | insulin pump | GLYCEMIC CONTROL | BOLUS CALCULATOR | TYPE-1 DIABETES-MELLITUS | TRIAL | RATES | ADOLESCENTS | ENDOCRINOLOGY & METABOLISM | HYPOGLYCEMIA | PEDIATRICS | PUMP THERAPY | YOUNG-CHILDREN | BASAL | Humans | Diabetic Ketoacidosis - etiology | Diabetes Mellitus, Type 1 - complications | Diabetes Mellitus, Type 1 - therapy | Hypoglycemia - prevention & control | Exercise | Hypoglycemic Agents - administration & dosage | Hypoglycemia - physiopathology | Diabetic Ketoacidosis - prevention & control | Child Behavior - drug effects | Diabetic Ketoacidosis - physiopathology | Hyperglycemia - physiopathology | Hypoglycemia - chemically induced | Child | Precision Medicine | Hypoglycemic Agents - therapeutic use | Severity of Illness Index | Hyperglycemia - prevention & control | Child Nutritional Physiological Phenomena - drug effects | Insulin Infusion Systems - adverse effects | Insulin - administration & dosage | Combined Modality Therapy - adverse effects | Adolescent Behavior - drug effects | Diabetes Mellitus, Type 1 - drug therapy | Infusions, Subcutaneous | Diet, Diabetic | Adolescent Nutritional Physiological Phenomena - drug effects | Diabetes Mellitus, Type 1 - blood | Adolescent | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Insulin - therapeutic use | Blood sugar monitoring | Type 1 diabetes | Insulin | Hyperglycemia | Diabetes mellitus | Liver | Ketoacidosis | Glucose | Children | Klinisk medicin | Clinical Medicine
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 12/2019, Volume 21, Issue 12, pp. 2619 - 2625
Aim To conduct a meta‐analysis to assess the effect of continuous subcutaneous insulin infusion (CSII), continuous glucose monitoring (CGM), and the... 
continuous subcutaneous insulin infusion | CGM | type 2 diabetes therapy | flash glucose monitoring | continuous glucose monitoring | FGM | CSII | Statistical analysis | Clinical trials | Hemoglobin | Glucose | Diabetes | Hypoglycemia | Diabetes mellitus (non-insulin dependent) | Insulin | Quality of life
Journal Article
Muscle & Nerve, ISSN 0148-639X, 01/2020, Volume 61, Issue 1, pp. 44 - 51
Introduction We assess whether improvement in control of type 1 diabetes mellitus (T1DM) with continuous subcutaneous insulin infusion (CSII) can protect... 
continuous subcutaneous insulin infusion | glycemic variability | type 1 diabetes mellitus | nerve excitability | neuroprotection | Diabetes mellitus | Peripheral nerves | Excitability | Diabetes mellitus (insulin dependent) | Insulin | Depolarization | Infusion | Restoration | Sodium | Hemoglobin | Diabetes | Membrane potential | Potassium
Journal Article
BMC Pediatrics, ISSN 1471-2431, 12/2013, Volume 13, Issue 1, pp. 212 - 212
Journal Article
Endocrine, ISSN 1355-008X, 1/2017, Volume 55, Issue 1, pp. 77 - 84
Journal Article